Categories AlphaGraphs, Earnings, Technology

NVDA Earnings: Nvidia Q3 profit, revenue beat Street view amid strong chip demand

Nvidia Corporation (NASDAQ: NVDA) has reported a 50% increase in third-quarter revenues, reflecting the strong demand for data-center and gaming chips. Both earnings and revenues exceeded Wall Street’s prediction.

The graphics chipmaker reported adjusted earnings of $1.17 per share for the October quarter, up from $0.73 per recorded a year earlier. Net income climbed to $2.46 billion or $0.97 per share from $1.34 billion or $0.53 per share in the third quarter of 2021.

Revenues grew 50 annually to $7.1 billion during the three-month period and came in above the estimates, helped by record revenue from the gaming, data center, and professional visualization market platforms.

“Demand for NVIDIA AI is surging, driven by hyper-scale and cloud scale-out, and broadening adoption by more than 25,000 companies. NVIDIA RTX has reinvented computer graphics with ray tracing and AI, and is the ideal upgrade for the large, growing market of gamers and creators, as well as designers and professionals building home workstations,” said Jensen Huang, chief executive officer of Nvidia.

Read management/analysts’ comments on Nvidia’s Q3 results

The company’s stock traded sharply higher in the early hours of Thursday, after closing the previous session lower. In the past twelve months, the value more than doubled.

Prior Performance

  • Nvidia Q2 2022 earnings infographic


Stocks you may like:

Apple (AAPL) Stock

Microsoft (MSFT) Stock

Alphabet (GOOGL) Stock

International Business Machines Corp. (IBM) Stock


Most Popular

HP Inc. (HPQ) stock research summary | Q3 2021

HP Inc has shown a strong performance in Q4 2021. In spite of remote working, HP has shown a strong demand for PC and printer. The company has beat Zacks

VMware Inc. (VMW) stock research summary | Q3 2021

In this era of digital transformation, the technology industry is seeing a rapid influx of innovative products and solutions that help businesses adapt to the fast-changing and complex environment. VMware

IPO Alert: Cancer drug company Nuvectis Pharma set for $30-million IPO

After months of hectic activity, the IPO market experienced a lull in the Thanksgiving week, but it is still headed for a record year though the rush led by the

Add Comment
Viewing Highlight